Literature DB >> 18450635

Dedifferentiated chordoma: a report of four cases arising 'de novo'.

S A Hanna1, R Tirabosco, A Amin, R C Pollock, J A Skinner, S R Cannon, A Saifuddin, T W R Briggs.   

Abstract

Dedifferentiated chordoma is a rare and aggressive variant of the conventional tumour in which an area undergoes transformation to a high-grade lesion, typically fibrous histiocytoma, fibrosarcoma, and rarely, osteosarcoma or rhabdomyosarcoma. The dedifferentiated component dictates overall survival, with smaller areas of dedifferentiation carrying a more favourable prognosis. Although it is more commonly diagnosed in recurrences and following radiotherapy, there have been a few reports of spontaneous development. We describe four such cases, which were diagnosed de novo following primary excision, and discuss the associated clinical and radiological features.

Entities:  

Mesh:

Year:  2008        PMID: 18450635     DOI: 10.1302/0301-620X.90B5.20365

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  11 in total

Review 1.  Spinal chordomas dedifferentiated to osteosarcoma: a report of two cases and a literature review.

Authors:  Satoshi Kato; Alessandro Gasbarrini; Riccardo Ghermandi; Marco Gambarotti; Stefano Bandiera
Journal:  Eur Spine J       Date:  2016-04-06       Impact factor: 3.134

Review 2.  Soft Tissue Special Issue: Chondroid Neoplasms of the Skull.

Authors:  A N Flaman; J K Wasserman; D H Gravel; B M Purgina
Journal:  Head Neck Pathol       Date:  2020-01-16

3.  Fifty-four-month survival in a 3-year-old child presenting with an aggressive metastatic dedifferentiated clival chordoma.

Authors:  Ciléin Kearns; Cónail Kearns
Journal:  BMJ Case Rep       Date:  2016-06-09

4.  Sacral chordoma in an adult showing an aggressive clinical course: A case report.

Authors:  Koji Endo; Hideki Yamashita; Hideki Nagashima; Ryota Teshima
Journal:  Oncol Lett       Date:  2014-02-19       Impact factor: 2.967

5.  Case report: Successful treatment of recurrent chordoma and bilateral pulmonary metastases following an 11-year disease-free period.

Authors:  Cherie P Erkmen; Richard J Barth; Vignesh Raman
Journal:  Int J Surg Case Rep       Date:  2014-05-02

Review 6.  Chordoma dedifferentiation after proton beam therapy: a case report and review of the literature.

Authors:  Joseph Frankl; Cassi Grotepas; Baldassare Stea; G Michael Lemole; Alexander Chiu; Rihan Khan
Journal:  J Med Case Rep       Date:  2016-10-12

7.  EGFR Inhibition in a Pretreated Sacral Chordoma: A Role for Erlotinib? Case Report and a Brief Review of Literature.

Authors:  D Trapani; F Conforti; T De Pas
Journal:  Transl Med UniSa       Date:  2017-07-01

8.  Isolated liver metastasis of sacrococcygeal chordoma: case report and review of the literature.

Authors:  Murat Akyol; Umut Varol; Ibrahim Yildiz; Ibrahim Vedat Bayoglu; Yasar Yildiz; Lutfiye Demir; Ahmet Dirican; Alper Can; Suna Cokmert; Mine Tunakan Oztop; Ahmet Alacacioglu; Yuksel Kucukzeybek; Mustafa Oktay Tarhan
Journal:  Case Rep Oncol Med       Date:  2014-06-11

9.  Application of nomograms to predict overall and cancer-specific survival in patients with chordoma.

Authors:  Weipeng Zheng; Yuanping Huang; Tianwang Guan; Songfang Lu; Liquan Yao; Senrui Wu; Haoyi Chen; Ning Wang; YingJie Liang; Wende Xiao; Xin Jiang; Shifeng Wen
Journal:  J Bone Oncol       Date:  2019-06-24       Impact factor: 4.072

10.  A Novel Nomogram for Predicting Cancer-Specific Survival in Patients With Spinal Chordoma: A Population-Based Analysis.

Authors:  Zhangheng Huang; Zhiyi Fan; Chengliang Zhao; He Sun
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.